TP53 mutations are infrequent in newly diagnosed chronic lymphocytic leukimia
TP53 mutations in the absence of 17p-deletion correlate with rapid disease progression and poor survival in chronic lymphocytic leukemia (CLL). Herein, we determined the TP53 mutation frequency in 268 newly diagnosed CLL patients from a population-based material. Overall, we detected TP53 mutations...
Main Authors: | Zainuddin, Norafiza, Murray, Fiona, Kanduri, Meena, Gunnarsson, Rebeqa, E. Smedby, Karin, Enblad, Gunilla, Jurlander, Jesper, Juliusson, Gunnar, Rosenquist, Richard |
---|---|
Format: | Article |
Language: | English |
Published: |
Pergamon
2011
|
Subjects: | |
Online Access: | http://irep.iium.edu.my/4434/ http://irep.iium.edu.my/4434/ http://irep.iium.edu.my/4434/ http://irep.iium.edu.my/4434/1/p53_CLL.pdf |
Similar Items
-
TP53 mutations are infrequent in newly diagnosed chronic lymphocytic leukimia
by: Zainuddin, Norafiza, et al.
Published: (2011) -
Lack of association between the MDM2 promoter polymorphism SNP309 and clinical outcome in chronic lymphocytic leukimia
by: Kaderi, Mohd Arifin, et al.
Published: (2010) -
Is a TNF alpha polymorphism responsible for mutations in the TP53 gene?
by: Berglund, Mattias, et al.
Published: (2011) -
TP53 mutations predict for poor survival in de novo diffuse
large B-cell lymphoma of germinal center subtype
by: Zainuddin, Norafiza, et al.
Published: (2008) -
Quantitative evaluation of p16INK4a promoter methylation using pyrosequencing in de novo diffuse large B-cell lymphoma
by: Zainuddin, Norafiza, et al.
Published: (2011)